Rhizoma alismatis lipid-reducing concentrated pill

Abstract

The invention relates to a rhizoma alismatis lipid-reducing concentrated pill. The pill is mainly prepared from the following raw medicinal materials in parts by weight: 20-30 parts of rhizoma alismatis, 6-12 parts of emblic leafflower fruit, 6-12 parts of fried rhizoma atractylodis macrocephalae, 6-12 parts of red yeast rice, 3-9 parts of lotus leaf and 3-9 parts of hawthorn. The invention aims to provide the rhizoma alismatis lipid-reducing concentrated pill for treating hyperlipidaemia, which is efficient, safe, low in price and convenient to take. The rhizoma alismatis lipid-reducing concentrated pill has the advantages that 1, the rhizoma alismatis lipid-reducing concentrated pill has the effects of promoting diuresis and strengthening spleen, activating blood circulation and removing food retention, and can be used for treating patients with syndromes of phlegm and stasis stagnation and dysfunction of spleen in transport caused by hyperlipidaemia; 2, the rhizoma alismatis lipid-reducing concentrated pill has the effects of improving dyslipidemia, cleaning free radicals in bodies, reinforcing body oxidation resistance and reducing liver fatty degeneration, and can be used for preventing and treating hyperlipidaemia, atherosclerosis, fatty liver and hyperlipidaemia related diseases.

Description

technical field [0001] The invention relates to a Alisma alisma-reducing fat-reducing concentrated pill for treating hyperlipidemia. Background technique [0002] Dyslipidemia has become a common health problem in human society in the 21st century. Clinical epidemiological survey data show that the TC levels of people in different regions are different, and the incidence and mortality of coronary heart disease are significantly different. At present, the status of dyslipidemia in the Chinese population is not optimistic. With the development of the economy, people's living standards continue to improve, and the development of urbanization and industrialization has changed people's diet and living habits. Physical activity has decreased, the proportion of obesity has increased, and the serum TC level of the population has shown an upward trend. The prevalence of dyslipidemia in my country is as high as 18.6%, which threatens the health of modern people. Hyperlipidemia is of...

AI Technical Summary

Problems solved by technology

But it is also a "double-edged sword". Inappropriate use of statins can lead to severe rhabdomyolysis and even death

Statins are currently a class of blood lipid-lowering drugs widely used in the primary and secondary prevention of cardiovascular and cerebrovascular diseases. They not only have lipid-lowering effects, but also can significantly reduce CRP levels. Difficult to overcome problems with large side effects

Fibrates will not aggravate insulin resistance or affect blood sugar control in diabetic patients. They are the first choice for diabetic patients with hyperlipidemia, but they can increase the concentration of cholesterol in bile and cause side effects such as gallstones, visual impairment and abnormal blood pictures. There are also adverse reactions such as gastrointestinal reactions, allergic reactions, etc.

[0004] Although countries around the world have conducted extensive and in-depth research on hyperlipidemia, there is still a lack of clinical drugs that are efficient, safe and suitable for the characteristics of patients in our country.

Images